Medication builds the bridge, but real, lasting recovery requires personal growth, therapeutic connection, and emotional healing
In June 2021, the agency approved Wegovy (semaglutide 2.4 mg once weekly) for weight management in adults with a body mass index (BMI) of 30 kg/m or greater (obesity), or a BMI of 27 kg/m or greater (overweight) with at least one weight-related comorbidity such as hypertension, dyslipidemia, or obstructive sleep apnea
Subcutaneous injections should be administered correctly, rotating injection sites to prevent lipohypertrophy (thickening of fatty tissue), which can impair drug absorption
Although, of course, Upadhye made clear, its hard to predict exactly what courts will do
Signalling the Brain: The medication acts on hunger centres to reduce appetite and "food noise." Insulin Regulation: It prompts insulin release when blood sugar is high and prevents the liver from releasing excess glucose
Foundayo is being studied for additional indications including type 2 diabetes, obstructive sleep apnea, and hypertension, suggesting its clinical profile may broaden further in the coming years
